Jenburkt Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Jenburkt Pharmaceuticals has a total shareholder equity of ₹1.6B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹1.8B and ₹237.1M respectively. Jenburkt Pharmaceuticals's EBIT is ₹353.6M making its interest coverage ratio -9.2. It has cash and short-term investments of ₹776.9M.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | -9.2x |
| Cash | ₹776.86m |
| Equity | ₹1.58b |
| Total liabilities | ₹237.15m |
| Total assets | ₹1.81b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524731's short term assets (₹1.0B) exceed its short term liabilities (₹177.0M).
Long Term Liabilities: 524731's short term assets (₹1.0B) exceed its long term liabilities (₹60.1M).
Debt to Equity History and Analysis
Debt Level: 524731 is debt free.
Reducing Debt: 524731 has no debt compared to 5 years ago when its debt to equity ratio was 6.2%.
Debt Coverage: 524731 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 524731 has no debt, therefore coverage of interest payments is not a concern.